医学
诱导疗法
内科学
克罗恩病
维持疗法
疾病
化疗
作者
Edward V. Loftus,Julián Panés,Ana P. Lacerda,Laurent Peyrin‐Biroulet,Geert D’Haens,Remo Panaccione,Walter Reinisch,Édouard Louis,Minhu Chen,Hiroshi Nakase,Jakob Begun,Brigid S. Boland,Charles D. Phillips,Mohamed‐Eslam F. Mohamed,Jianzhong Liu,Ziqian Geng,Feng Tian,Elena Dubcenco,Jean‐Frédéric Colombel
标识
DOI：10.1056/nejmoa2212728
摘要
Upadacitinib induction and maintenance treatment was superior to placebo in patients with moderate-to-severe Crohn's disease. (Funded by AbbVie; U-EXCEL, U-EXCEED, and U-ENDURE ClinicalTrials.gov numbers, NCT03345849, NCT03345836, and NCT03345823.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
Copyright
cdercder
Nole
潇洒的惋清
大力的冬萱
Criminology34
key
愉快的真
美好斓
风清扬
Oracle
arniu2008
嘉心糖
liuzhuohao
Nexus
loii
OK
挣积分换文献的大飞
aajhajkahna
皖公网安备34019202002308
